Company news
DaShenLin Pharmaceutical Group Co., Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
(603233)"DaShenLin Pharmaceutical Group Co., Ltd."Report for Q3 2026
October 29, 2026
(603233)"DaShenLin Pharmaceutical Group Co., Ltd."Notice on Convening the 3rd Extraordinary General Meeting in 2026
October 29, 2026
(603233)"DaShenLin Pharmaceutical Group Co., Ltd."Announcement on Resolutions of the 4th Meeting of the 5th Board of Directors
October 29, 2026
(603233)"DaShenLin Pharmaceutical Group Co., Ltd."Announcement on Progress in Providing Guarantees for Subsidiaries
October 29, 2026
(603233)"DaShenLin Pharmaceutical Group Co., Ltd."Announcement on Key Operating Data for Q3 2026
October 29, 2026
(603233)"DaShenLin Pharmaceutical Group Co., Ltd."Announcement on Employee Stock Ownership Platform's Equity Investment in Subsidiaries
October 29, 2026
(603233)"DaShenLin Pharmaceutical Group Co., Ltd."Announcement on Change of Use of Repurchased Shares and Cancellation Thereof
October 29, 2026
(603233)"DaShenLin Pharmaceutical Group Co., Ltd."Announcement on Change of Relevant Commitments by the Controlling Shareholder and Actual Controller
October 29, 2026
(603233)"DaShenLin Pharmaceutical Group Co., Ltd."Announcement on Change of Head of Internal Audit Department
October 29, 2026
(603233)"DaShenLin Pharmaceutical Group Co., Ltd."Announcement on Change of Business Scope and Amendment to the Articles of Association
October 29, 2026
(603233)"DaShenLin Pharmaceutical Group Co., Ltd."Announcement on Capital Increase in Controlled Subsidiary Canli Technology and Related Party Transaction
October 29, 2026
(603233)"DaShenLin Pharmaceutical Group Co., Ltd."Announcement on Adjustment of Remuneration Plan for Independent Directors
October 29, 2026
(603233)"DaShenLin Pharmaceutical Group Co., Ltd."Announcement on Results of Redemption at Maturity of "DaShenLin Convertible Bonds" and Share Changes
October 22, 2026
(603233)"DaShenLin Pharmaceutical Group Co., Ltd."Announcement on Redemption at Maturity and Delisting of "DaShenLin Convertible Bonds"
October 13, 2026
(603233)"DaShenLin Pharmaceutical Group Co., Ltd."Announcement on Implementation of Dividend Distribution for the First Half of 2026
October 11, 2026
Announcement on Adjustment of the Conversion Price of "DaShenLin Convertible Bonds"
October 11, 2026
(603233)"DaShenLin Pharmaceutical Group Co., Ltd."Announcement on Conversion Results of Convertible Bonds and Share Changes
October 8, 2026
(603233)"DaShenLin Pharmaceutical Group Co., Ltd."Indicative Announcement on Suspension of Conversion of "DaShenLin Convertible Bonds" During the Implementation of Dividend Distribution for the First Half of 2026
September 28, 2026
(603233)"DaShenLin Pharmaceutical Group Co., Ltd."Announcement on Progress in Providing Guarantees for Subsidiaries
September 28, 2026
Third Indicative Announcement on Redemption at Maturity and Delisting of "DaShenLin Convertible Bonds"
September 28, 2026
Announcement on Convening the 2026 Semi-annual Performance Briefing
September 21, 2026
First Indicative Announcement on Maturity Redemption and Delisting of "DaShenLin Convertible Bonds"
September 15, 2026
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
September 11, 2026
Notice on Convening the 2nd Extraordinary General Meeting in 2026
August 24, 2026
Announcement on Reply to the Inquiry Letter on the Company's 2025 Annual Report
July 20, 2026
Announcement on Conversion Result of Convertible Bonds and Share Changes
July 1, 2026
Announcement on Progress in Providing Guarantee for Subsidiary
June 25, 2026
in 2026
June 24, 2026
Announcement on Adjustment of the Conversion Price of the “Dashenlin Convertible Bonds"
June 17, 2026
Indicative Announcement on Suspending Conversion of “Dashenlin Convertible Bonds" during the Implementation of Dividend Distribution for 2025
June 10, 2026
Indicative Announcement on Impending Expiration of 2020 Employee Stock Ownership Plan
May 27, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 18, 2026
Indicative Announcement on Change of the Meeting Date of the 2025 Annual General Meeting
May 11, 2026
Announcement on Convening Performance Briefing for 2025 and Q1 2026
May 8, 2026
Announcement on Resolutions of the 2nd Meeting of the 5th Board of Directors
April 23, 2026
Announcement on Conversion Result of Convertible Bonds and Share Changes
April 2, 2026
Announcement on the Completion of Board of Directors Re-election and the Election of Company Chairman, Members of Special Committees under the Board of Directors, as well as the Appointment of Senior Management Member and Securities Affairs Representative
March 31, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
March 30, 2026
Announcement on Election of Board of Directors at Expiry of Term of Office
March 13, 2026
Announcement on Release of Pledge of Partial Shares of Controlling Shareholders
December 19, 2025
Announcement on Convening the Q3 2025 Performance Briefing
December 1, 2025
Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
November 21, 2025
Announcement on Resolutions of the 28th Meeting of the 4th Board of Directors
October 29, 2025
Indicative Announcement on Suspending Conversion of “Dashenlin Convertible Bonds" during the Implementation of Semi-annual Dividend Distribution for 2025
October 22, 2025
Announcement on the Interest Payment of Convertible Corporate Bonds in 2025
October 14, 2025
Announcement on Progress in Providing Guarantees for Subsidiaries
September 29, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
September 17, 2025
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
September 15, 2025
Announcement on the Change in Equity of Shareholders with Over 5% Shares Reaching 1% Scale and the Completion of the Shareholding Reduction Plan
September 10, 2025
Notice on Convening the 2nd Extraordinary General Meeting in 2025
August 28, 2025